PRN-1371

N/A

Report date: 2022/07/19 20:00:45

NME

Base Information

Drug NamePRN-1371

Drug Alias NamePRN-1371

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptor 4 antagonistsFibroblast growth factor receptor 3 antagonistsFibroblast growth factor receptor 1 antagonists +[4]

TargetsFibroblast growth factor receptor 4Fibroblast growth factor receptor 1Fibroblast growth factor receptor 3 +[4]

Therapy Area/IndicationsSolid tumoursCarcinoma, Transitional Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSpain

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPrincipia Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPrincipia Biopharma Inc

Active IndicationsN/A

Inactive IndicationsSolid tumoursCarcinoma, Transitional Cell

Other Information

ATC CodeN/A